Oleic acid enhances all-trans retinoic acid loading in nano-lipid emulsions

PDA Journal of Pharmaceutical Science and Technology

Volumn 64, Issue 2, 2010, Pages 113-123

  Akhayachatra, Chinsriwongkul ^a   Praneet, Opanasopit ^a   Tanasait, Ngawhirunpat ^a   Rojanarata, Theerasak ^a   Sila On, Warisada ^b   Ruktanonchai, Uracha ^a,c  

^a SILPAKORN UNIVERSITY   (Thailand)

^b Department of Mathematics   (Thailand)

^c NATIONAL SCIENCE AND TECHNOLOGY DEVELOPMENT AGENCY   (Thailand)

Author keywords

All trans retinoic acid; Lipid emulsions; Nanoemulsions; Oleic acid

Indexed keywords

LIPID EMULSION; OIL; OLEIC ACID; RETINOIC ACID; WATER; EMULSION;

ARTICLE; CONCENTRATION (PARAMETERS); PARTICLE SIZE; PHOTODEGRADATION; PHYSICAL CHEMISTRY; SOLUBILITY; SOYBEAN; ZETA POTENTIAL; CHEMISTRY; EMULSION; MEDICINAL CHEMISTRY;

CHEMISTRY, PHARMACEUTICAL; EMULSIONS; FAT EMULSIONS, INTRAVENOUS; OLEIC ACID; PARTICLE SIZE; PHYSICOCHEMICAL PHENOMENA; SOLUBILITY; TRETINOIN;

EID: 78149297834     PISSN: 10797440     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Otsuki, T.; Sakaguchi, H.; Hatayama, T.; Wu, P.; Takata, A.; Hyodoh, F. Effects of all-trans retinoic acid (ATRA) on human myeloma cells. Leuk. Lymphoma 2003, 44 (10), 1651-1656.
2. Lengfelder, E.; Saussele, S.; Weisser, A.; Buchner, T.; Hehlmann, R. Treatment concepts of acute promyelocytic leukemia. Crit. Rev. Oncol. Hematol. 2005, 56 (2), 261-274.
3. Muindi, J.; Frankel, S. R.; Miller, W. H.; Jakubowski Jr., A.; Scheinberg, D. A.; Young, C. W.; Dmitrovsky, E.; Warrell Jr., R. P. Continuous treatment with all-trans retinoic acid causes a progressive reduction in plasma drug concentrations: implications for relapse and retinoid " resistance" in patients with acute promyelocytic leukemia. Blood 1992, 79 (2), 299-303.
4. Ozpolat, B.; Lopez-Berestein, G. Liposomal-all-trans-retinoic acid in treatment of acute promyelocytic leukemia. Leuk. Lymphoma 2002, 43 (5), 933-941.
5. Estey, E.; Koller, C.; Tsimberidou, A. M.; O'Brien, S.; Beran, M.; Cortes, J.; Tirado-Gomez, M.; Lopez-Berestein, G.; Kantarjian, H. Potential curability of newly diagnosed acute promyelocytic leukemia without use of chemotherapy: the example of liposomal all-trans retinoic acid. Blood 2005, 105 (3), 1366-1367.
6. Lim, S. J.; Lee, M. K.; Kim, C. K. Altered chemical and biological activities of all-trans retinoic acid incorporated in solid lipid nanoparticle powders. J. Controlled. Release 2004, 100 (1), 53-61.
7. Kawakami, S.; Opanasopit, P.; Yokoyama, M.; Chansri, N.; Yamamoto, T.; Okano, T.; Yamashita, F.; Hashida, M. Biodistribution characteristics of all-trans retinoic acid incorporated in liposomes and polymeric micelles following intravenous administration. J. Pharm. Sci. 2005, 94 (12), 2606-2615.
8. Opanasopit, P.; Ngawhirunpat, T.; Rojanarata, T.; Choochottiros, C.; Chirachanchai, S. N-phthaloylchitosan-g-mPEG design for all-trans retinoic acid-loaded polymeric micelles. Eur J Pharm Sci. 2007, 30 (5), 424-431.
9. Hwang, S. R.; Lim, S. J.; Park, J. S.; Kim, C. K. Phospholipid-based microemulsion formulation of all-trans-retinoic acid for parenteral administration. Int. J. Pharm. 2004. 276 (1-2), 175-183.
10. Chinsriwongkul, A.; Opanasopit, P.; Ngawhirunpat, T.; Chareansriwilaiwat, N.; Sila-On, W.; Ruktanonchai, U. Physicochemical properties of lipid emulsions formulated with high-load all-trans-retinoic acid. PDA J. Pharm. Sci. Technol. 2007, 61 (6), 461-471. (Pubitemid 351158427)
11. Prankerd, R. J.; Stella, V. J. The use of oil-inwater emulsion as a vehicle for parenteral drug administration. J. Parent. Sci. Technol. 1990, 44 (3), 139-149.
12. Sznitowka, M.; Janicki, S.; Dabrowska, E.; Zurowska-Pryczkowska, K. Submicron emulsions as drug carriers. Studies on destabilization potential of various drugs. Eur. J. Pharm. Sci. 2001, 12 (3), 175-179.
13. Benita, S.; Friedman, D.; Weinstock, M. Physostigmine emulsion: a new injectable controlled release delivery system. Int. J. Pharm. 1986, 30 (1), 47-55.
14. Myers, R. A.; Stella, V. J. Systemic bioavailability of penclomedine (NSC-338720) from oil-in-water emulsions administered intraduodenally to rats. Int. J. Pharm. 1992, 78 (2-3), 217-220.
15. Kaur, I. P.; Rana, C.; Singh, H. Development of effective ocular preparations of antifungal agents. J. Ocul. Pharmacol. Ther. 2008, 24 (5), 481-493
16. Tamilvanan, S.; Benita, S. The potential of lipid emulsion for ocular delivery of lipophilic drugs. Eur. J. Pharm. Biopharm. 2004, 58 (2), 357-368.
17. Gershkovich, P.; Wasan, K. M.; Barta, C. A. A review of the application of lipid-based systems in systemic, dermal/transdermal, and ocular drug delivery. Crit Rev. Ther. Drug Carrier Syst. 2008, 25 (6), 545-84.
18. Levy, M. Y.; Schutze, W.; Fuhrer, C.; Benita, S. Characterization of diazepam submicron emulsion interface: role of oleic acid. J. Microencapsul. 1994, 11 (1), 79-92.
19. Tamilvanan, S.; Schmidt, S.; Müller, R. H.; Benita, S. In vitro adsorption of plasma proteins onto the surface (charges) modified-submicron emulsions for intravenous administration. Eur. J. Pharm Biopharm. 2005, 59 (1), 1-7.
20. Caddeo, C.; Manconi, M.; Valenti, D.; Pini, E.; Sinico, C. Photostability and solubility improvement of β-cyclodextrin-included tretinoin. J. Incl. Phenom. Macrocycl. Chem. 2007, 59 (3-4), 293-300.
21. Klang, S.; Benita, S. Design and evaluation of submicron emulsions as colloidal drug carriers for intravenous administration. In Submicron Emulsions in Drug Targeting and Delivery; Harwood Academic Publishers: Singapore, 1998; pp 119-152.
22. Driscoll, D. F.; Giampietro, K.; Wichelhaus, D. P.; Peterss, H.; Nehne, J.; Niemann, W.; Bistrian, B. R. Physicochemical stability assessments of lipid emulsions of varying oil composition. Clin. Nutr. 2001, 20 (2), 151-7.
23. Brisaert, M.; Plaizier-Vercammen, J. Investigation on the Photostability of a tretinoin lotion and stabilization with additives. Int. J. Pharm. 2000, 199 (1), 49-57.
24. Lin, H. S.; Chean, C. S.; Ng, Y. Y.; Chan, S. Y.; Ho, P. C. 2-hydroxypropyl-beta-cyclodextrin increases aqueous solubility and photostability of all-trans-retinoic acid. J. Clin. Pharm. Ther. 2000, 25 (4), 265-269.
25. Washington, C.; Davis, S. Aging effects in parenteral fat emulsions: The role of fatty acids. Int. J. Pharm. 1987, 39 (1-2), 33-37. (Pubitemid 17137272)
26. Brisaert, M. G.; Everaerts, I.; Plaizier-Vercammen, J. A. Chemical stability of tretinoin in dermatological preparations. Pharm. Acta Helv. 1995, 70 (2), 161-166.
27. Carlotti, M. E.; Rossatto, V.; Gallarate, M. Vitamin A and vitamin A palmitate stability over time and under UVA and UVB radiation. Int. J. Pharm. 2002, 240 (1-2), 85-94.
28. Ioele, G.; Cione, E.; Risoli, A.; Genchi, G.; Ragno, G. Accelerated photostability study of tretinoin and isotretinoin in liposome formulations. Int. J. Pharm. 2005, 293 (1-2), 251-260. (Pubitemid 40381097)
29. Manconi, M.; Valenti, D.; Sinico, C.; Lai, F.; Loy, G.; Fadda, A. M. Niosomes as carriers for tretinoin. II. Influence of vesicular incorporation on tretinoin photostability. Int. J. Pharm. 2003, 260 (2), 261-272.
30. Shah, K. A.; Date, A. A.; Joshi, M. D.; Patravale, V. B. Solid lipid nanoparticles (SLN) of tretinoin: potential in topical delivery. Int. J. Pharm. 2007, 345 (1-2), 163-171. (Pubitemid 350087549)
31. Tan, X.; Meltzer, N.; Lindenbaum, S. Determination of the kinetics of degradation of 13-cis retinoic acid and all-trans retinoic acid in solution. J. Pharm. Biomed. Anal. 1993, 11 (9), 817-822.
32. Ourique, A. F.; Pohlmann, A. R.; Guterres, S. S.; Beck, R. C. Tretinoin-loaded nanocapsules: Preparation, physicochemical characterization, and photostability study. Int. J. Pharm. 2008, 352 (1-2), 1-4.
33. Yuan, H.; Wang, L. L.; Du, Y. Z.; You, J.; Hu, F. Q.; Zeng, S. Preparation and characteristics of nanostructured lipid carriers for control-releasing progesterone by melt-emulsification. Colloids Surf. B Biointerfaces 2007, 60 (2), 174-179.